IMF Videos Search Content For Healthcare Professional (182) Healthcare Provider (182) Series - Any - About the IMF (2) ASCO/EHA (163) ASH (230) Ask Dr. Durie (247) Black Swan Research Initiative (7) Community Workshops (33) Emerging Therapies (20) Facebook Live (21) Health Equity (16) IMF History (4) IMWG (13) Inspirational (16) Living Well with Myeloma (34) Myeloma in a Minute (19) Myeloma Made Simple (15) Myeloma University (12) NLB Webcasts (1) Patient & Family Webinar (27) Q&A (19) Recent News and Developments (4) Treatments (4) Trending Searches in Myeloma (1) Topics Clinical Trials (136) Financial Considerations (1) Frontline Therapy (34) Health Equity (10) Inspirational Stories (1) Lab & Imaging Tests (26) Lifestyle (4) Mental & Emotional Health (1) Public Policy & Advocacy (1) Recorded Webinars (2) Relapse/Refractory Myeloma (80) Research Updates (151) Symptom Management (8) Myeloma Stage Early Relapse (1–3 Lines of Therapy) (31) High-Risk Myeloma (29) High-risk Smoldering Myeloma (13) Late Relapse (4–6 Lines of Therapy) (63) MGUS (18) Newly Diagnosed (Pre-Treatment or First Treatment) (52) Smoldering Myeloma (22) Types of Therapy Immunomodulatory drugs (IMiDs) (57) Immunotherapies (CAR T; BiTE, etc.) (60) Monoclonal antibodies (49) Proteasome inhibitors (50) Stem cell transplant (38) Steroids (21) Supportive Care (17) Year Published 2026 (7) 2025 (24) 2024 (23) 2023 (21) 2022 (34) 2021 (27) 2020 (18) 2019 (32) 2018 (30) 2017 (5) 2016 (3) 2015 (6) Trusted Voices Dr. María-Victoria Mateos (8) Dr. Saad Usmani (4) Dr. Shaji Kumar (4) Dr. Brian GM Durie (3) Dr. Joseph Mikhael (3) Dr. Sagar Lonial (1) Dr. Sigurður Kristinsson (1) Dr. Tom Martin (1) Sort Newest firstOldest firstA -> ZZ -> ARelevance One-Year Update of Alcyone: Phase 3 Randomized Study of D-VMP Versus VMP in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma December 3, 2018 ASH Efficacy and Safety of P-BCMA-101 CAR-T Cells in Patients with Relapsed/Refractory Multiple Myeloma December 3, 2018 ASH Venetoclax Plus Carfilzomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma December 2, 2018 ASH Seeking AL Amyloidosis Very Early: The SAVE Trial December 2, 2018 ASH Preliminary Outcome from the Open Label Phase II ALLGMM018/AMN003 Study December 2, 2018 ASH Proposed 2019 treatment algorithms for Multiple Myeloma November 30, 2018 ASH Advances in therapeutic strategies for patients with relapsed/refractory myeloma November 30, 2018 ASH Recent data on transplantation, consolidation, and maintenance after induction therapy November 30, 2018 ASH Are we ready for personalized therapy in newly diagnosed MM? November 30, 2018 ASH Risk stratification of plasma cell disorders November 30, 2018 ASH New Strategies for Multiple Myeloma Care: Next Steps for the Future November 30, 2018 ASH Curative Strategy for High-Risk Smoldering Myeloma (GEM-CESAR) January 3, 2018 ASH Load More
